240
Views
2
CrossRef citations to date
0
Altmetric
Pharmacotherapy

The Effect of Administrative Cessation of the Use of Ipratropium Bromide in the Treatment of Acute Asthma Attacks in the Emergency Department

, M.d., , M.A., , M.Sc., , Ph.D., , M.D., , M.B.A. & , M.d. show all
Pages 1063-1068 | Published online: 11 Nov 2011

References

  • Westby M, Benson M, Gibson P. Anticholinergic agents for chronic asthma in adults. Cochrane Database Syst Rev 2004; 3:CD003269.
  • Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis. Thorax 2005; 60:740–746.
  • Iwamota H, Yokoyama A, Shiota N, Shoda H, Haruta Y, Hattori N, Kohno N. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J 2008; 31:1379–1380.
  • Park HW, Yang MS, Park CS, Kim TB, Moon HB, Min KU, Kim YY, Cho SH. Additive role of tiotropium in severe asthmatics and Arg16Gly in ADRB2 as a potential marker to predict response. Allergy 2009; 64:778–783.
  • Ogale SS, Lee TA, Au DH, Kim TB, Moon HB, Min KU, Kim YY, Cho SH. Cardiovascular events associated with ipratropium bromide in COPD. Chest 2010; 137(1):13–19.
  • Camargo CA, Rachelefsky G, Schatz M. Managing asthma exacerbations in the emergency department. Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 Guidelines for the Management of Asthma Exacerbations. Proc Am Thorac Soc 2009; 76:357–366.
  • Schatz M, Kazzi AA, Brenner B, Camargo CA Jr, Corbridge T, Krishnan JA, Nowak R, Rachelefsky G. The Joint Task Force report: supplemental recommendation for the management and follow-up of asthma exacerbations. Proc Am Thorac Soc 2009; 6:353–356.
  • Van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007; 16:219–242.
  • Donahue JG, Weiss ST, Livingston JM, Camargo CA Jr, Corbridge T, Krishnan JA, Nowak R, Rachelefsky G. Inhaled steroids and the risk of hospitalization for asthma. J Am Med Assoc 1997; 277:887–891.
  • Anis AH, Lynd LD, Wang X, et al. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001; 164:625–631.
  • Siossa S, Ermst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax 2002; 57:880–884.
  • Garrett J, Kolbe J, Richards G, Whitlock T, Rea H. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax 1995; 50:303–311.
  • Sly RM. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs. Ann Allergy 1994; l73:439–443.
  • Lanes SF, Garcia Rodriguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax 2002; 57:683–386.
  • Goldman M, Rachmiel M, Gendler L, Katz Y. Decrease in asthma mortality rate in Israel from 1991–1995: is it related to increased use of inhaled corticosteroids? J Allergy Clin Immunol 2000; 105:71–74.
  • GINA (Global Initiative for Asthma). Global Strategy for Asthma Management and Prevention. Bethesda, MD: National Institutes of Health, National Heart Lung and Blood Institute, 2008.
  • Weber EJ, Silverman RA, Callaham ML, Pollack CV, Woodruff PG, Clark S, Camargo CA Jr. A prospective multicenter study of factors associated with hospital admission among adults with acute asthma. Am J Med 2002; 113:371–378.
  • Lynd LD, Guh DP, Pare PD, Anis AH. Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest 2002; 122:1973–1981.
  • Waisel Y, Ganor E, Glikman M, Epstein V, Brenner S. Seasonal distribution of airborne pollen in the coastal plain of Israel. Aerobiologia 1997; 13:127–134.
  • Menckeberg TT, Belitser SV, Bouvy ML, Bracke M, Lammers JW, Raaijmakers JA, Leufkens HG. Distinguishing patterns in the dynamics of long-term medication use by Markov analysis: beyond persistence. BMC Health Serv Res 2007; 7:106–114.
  • Moorman JE, Zahran H, Truman BI, Molla MT. Current asthma prevalence – United States, 2006–2008. Center for Disease Control and Prevention: Morbidity and Mortality Weekly Report; 14 January 2011: 60:84–86.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.